PUR003 Program(PurMinds NeuroPharma)

N/A

Report date: 2022/12/16 17:04:25
NME

Base Information

Drug NamePUR003 Program(PurMinds NeuroPharma)
Drug Alias NamePUR-003(PurMinds NeuroPharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPurminds Neuropharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesPurminds Neuropharma Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A